Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Biologic Assignment Trial Comparing Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients w/Intermediate-2 & High Risk Myelodysplastic Syndrome (BMTCTN1102)

NCT02016781 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT02016781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Biologic Assignment Trial Comparing Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients w/Intermediate-2 & High Risk Myelodysplastic Syndrome (BMTCTN1102)
Lead sponsor
Medical College of Wisconsin
Phase
Phase 2
Overall status
Completed
Start date
December 16, 2013
Completion date
October 5, 2021
Enrollment
384 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

mds